Beijing recalls bottled water that failed safety tests

By Admin
Thirty-one brands of bottled water have been removed from sale in Beijing after they failed to pass safety tests. It was discovered during random inspe...

Thirty-one brands of bottled water have been removed from sale in Beijing after they failed to pass safety tests.

It was discovered during random inspections that the bottled waters contained high levels of bacteria colonies, Beijing authorities said.

Yiqun is one brand of bottled water that has been removed from sale in the city after it was found to have 9,000 times more bacteria than the safety standards level.

Meanwhile, bacteria levels in Tianxing Special Water were reportedly 560 times above the safety threshold.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

It is thought that drinking water with high levels of bacteria in it can cause a number of health problems, including vomiting, diarrhoea and dizziness.

Authorities believe some of the problems have been caused during the production process and can be attributed to a break down in factory-based quality control practices, such as a failure to sterilise water pipes and filters.

The Beijing Administration for Industry and Commerce worked in partnership with the city’s product quality bureau to carry out the tests.

In a statement on their website the Administration explained the reason for the halt on sales, saying: “In order to prevent these substandard products from entering the distribution chain, the product quality bureau has taken measures to halt sales.”

This is the latest health scare in a long line of such incidences that have hit China in recent years.

Fruit, pork and milk have come to the surface in the last few months as being unsafe for human consumption, although 2008 saw China experience a mammoth health scare.

Six babies died and over 300,000 people fell ill with kidney stones after milk was found to be tainted with melamine. 

Share

Featured Articles

Comarch Diagnostic Point Boost for European Health Insurance

Healthtech specialist Comarch introduces Diagnostic Point, designed to improve health insurance across European markets

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Procurement & Supply Chain

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma